Katy Burnett's most recent trade in Bluebird bio Inc was a trade of 2,000 Common Stock done . Disclosure was reported to the exchange on Feb. 16, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bluebird bio Inc | Katy Burnett | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,000 | 3,188 (0%) | 0% | 0 | Common Stock | |
Bluebird bio Inc | Katy Burnett | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,427 | 4,615 (0%) | 0% | 0 | Common Stock | |
Bluebird bio Inc | Katy Burnett | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 518 | 4,097 (0%) | 0% | 28.2 | 14,588 | Common Stock |
Bluebird bio Inc | Katy Burnett | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 46.09 per share. | 03 Dec 2020 | 123 | 1,460 (0%) | 0% | 46.1 | 5,669 | Common Stock |